The safety and efficacy of remimazolam tosylate for induction and maintenance of general anesthesia in pediatric patients undergoing elective surgery: Study protocol for a multicenter, randomized, single-blind, positive-controlled clinical trial

Yu-Bo Fang, Cheng-Yu Wang, Yu-Qing Gao, Yu-Hang Cai, Jia Chen, Xu-Lin Zhang, Le-Qi Dong, Wang-Ning Shang-Guan, Hua-Cheng Liu, Yu-Bo Fang, Cheng-Yu Wang, Yu-Qing Gao, Yu-Hang Cai, Jia Chen, Xu-Lin Zhang, Le-Qi Dong, Wang-Ning Shang-Guan, Hua-Cheng Liu

Abstract

Introduction: Remimazolam is an ultra-short-acting benzodiazepine sedative agent commonly used in general anesthesia, procedural sedation, and intensive care unit (ICU) sedation. This study aimed to explore the efficacy and safety of remimazolam versus propofol for the induction and maintenance of general anesthesia in preschool-age children undergoing elective surgery. Methods and analysis: In this multicenter, randomized, single-blind, positive-controlled non-inferior clinical trial, one hundred ninety-two children aged 3-6 years will be randomly allocated as a 3:1 ratio into two groups: Group R with an intravenous dose of remimazolam 0.3 mg/kg for the induction of anesthesia followed by a constant infusion rate of remimazolam 1-3 mg/kg/h to maintain anesthesia, and Group P with an intravenous dose of propofol 2.5 mg/kg for the induction of anesthesia followed by a constant infusion rate of propofol 4-12 mg/kg/h to maintain anesthesia. The primary outcome will be the rate of the successful induction and maintenance of anesthesia. The secondary outcomes will include the time to LoC, the Bispectral Index (BIS) value, awakening time, extubation time, post-anesthesia care unit (PACU) discharge time, usage of additional sedative drugs during the induction period, usage of remedial drugs in PACU, emergence delirium, pain in PACU, behavior scores at day 3 after surgery, parental and anesthesiologists' satisfaction, and adverse events. Ethics and dissemination: This study has been approved by the ethics review boards at all participating hospitals. The Ethics Committee of the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University (Reference No. LCKY 2020-380, November 13, 2020) is the central ethics committee.

Keywords: efficacy; general anesthesia; pediatric patients; propofol; remimazolam.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2023 Fang, Wang, Gao, Cai, Chen, Zhang, Dong, Shang-Guan and Liu.

References

    1. Al-Jahdari W. S., Yamamoto K., Hiraoka H., Nakamura K., Goto F., Horiuchi R. (2006). Prediction of total propofol clearance based on enzyme activities in microsomes from human kidney and liver. Eur. J. Clin. Pharmacol. 62 (7), 527–533. 10.1007/s00228-006-0130-2
    1. Antonik L. J., Goldwater D. R., Kilpatrick G. J., Tilbrook G. S., Borkett K. M. (2012). A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics. Anesth. Analg. 115 (2), 274–283. 10.1213/ANE.0b013e31823f0c28
    1. Baruteau A. E., Perry J. C., Sanatani S., Horie M., Dubin A. M. (2016). Evaluation and management of bradycardia in neonates and children. Eur. J. Pediatr. 175 (2), 151–161. 10.1007/s00431-015-2689-z
    1. Buchwald P. (2020). Soft drugs: Design principles, success stories, and future perspectives. Expert Opin. Drug Metab. Toxicol. 16 (8), 645–650. 10.1080/17425255.2020.1777280
    1. Cavuoto K. M., Rodriguez L. I., Tutiven J., Chang T. C. (2014). General anesthesia in the pediatric population. Curr. Opin. Ophthalmol. 25 (5), 411–416. 10.1097/icu.0000000000000088
    1. Chae D., Kim H. C., Song Y., Choi Y. S., Han D. W. (2022). Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia: A randomised, prospective, double-blind study. Br. J. Anaesth. 129 (1), 49–57. 10.1016/j.bja.2022.02.040
    1. Chen S. H., Yuan T. M., Zhang J., Bai H., Tian M., Pan C. X., et al. (2021). Remimazolam tosilate in upper gastrointestinal endoscopy: A multicenter, randomized, non-inferiority, phase III trial. J. Gastroenterol. Hepatol. 36 (2), 474–481. 10.1111/jgh.15188
    1. Chen S., Wang J., Xu X., Huang Y., Xue S., Wu A., et al. (2020a). The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: A multicentered, randomized, positive-controlled, phase III clinical trial. Am. J. Transl. Res. 12 (8), 4594–4603.
    1. Chen X., Sang N., Song K., Zhong W., Wang H., Jiang J., et al. (2020b). Psychomotor recovery following remimazolam-induced sedation and the effectiveness of flumazenil as an antidote. Clin. Ther. 42 (4), 614–624. 10.1016/j.clinthera.2020.02.006
    1. Chen X., Xin D., Xu G., Zhao J., Lv Q. (2022). The efficacy and safety of remimazolam tosilate versus dexmedetomidine in outpatients undergoing flexible bronchoscopy: A prospective, randomized, blind, non-inferiority trial. Front. Pharmacol. 13, 902065. 10.3389/fphar.2022.902065
    1. Chidambaran V., Costandi A., D'Mello A. (2015). Propofol: A review of its role in pediatric anesthesia and sedation. CNS Drugs 29 (7), 543–563. 10.1007/s40263-015-0259-6
    1. Choi J. Y., Lee H. S., Kim J. Y., Han D. W., Yang J. Y., Kim M. J., et al. (2022). Comparison of remimazolam-based and propofol-based total intravenous anesthesia on postoperative quality of recovery: A randomized non-inferiority trial. J. Clin. Anesth. 82, 110955. 10.1016/j.jclinane.2022.110955
    1. Crellin D. J., Harrison D., Santamaria N., Huque H., Babl F. E. (2018). The psychometric properties of the FLACC scale used to assess procedural pain. J. Pain 19 (8), 862–872. 10.1016/j.jpain.2018.02.013
    1. Dai G., Pei L., Duan F., Liao M., Zhang Y., Zhu M., et al. (2021). Safety and efficacy of remimazolam compared with propofol in induction of general anesthesia. Minerva Anestesiol. 87 (10), 1073–1079. 10.23736/s0375-9393.21.15517-8
    1. Deng Y., Qin Z., Wu Q., Liu L., Yang X., Ju X., et al. (2022). Efficacy and safety of remimazolam besylate versus dexmedetomidine for sedation in non-intubated older patients with agitated delirium after orthopedic surgery: A randomized controlled trial. Drug Des. Devel Ther. 16, 2439–2451. 10.2147/dddt.S373772
    1. Doi M., Morita K., Takeda J., Sakamoto A., Yamakage M., Suzuki T. (2020). Efficacy and safety of remimazolam versus propofol for general anesthesia: A multicenter, single-blind, randomized, parallel-group, phase IIb/III trial. J. Anesth. 34 (4), 543–553. 10.1007/s00540-020-02788-6
    1. Eisenried A., Schüttler J., Lerch M., Ihmsen H., Jeleazcov C. (2020). Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: Part II. Pharmacodynamics of electroencephalogram effects. Anesthesiology 132 (4), 652–666. 10.1097/aln.0000000000003102
    1. Gentili A. (2020). Propofol: An intravenous anesthetic suitable for pediatric age. Minerva Anestesiol. 86 (4), 374–376. 10.23736/s0375-9393.20.14380-3
    1. Grasso C., Marchesini V., Disma N. (2021). Applications and limitations of neuro-monitoring in paediatric anaesthesia and intravenous anaesthesia: A narrative review. J. Clin. Med. 10 (12), 2639. 10.3390/jcm10122639
    1. Green S. M., Leroy P. L., Roback M. G., Irwin M. G., Andolfatto G., Babl F. E., et al. (2020). An international multidisciplinary consensus statement on fasting before procedural sedation in adults and children. Anaesthesia 75 (3), 374–385. 10.1111/anae.14892
    1. Haque I. U., Zaritsky A. L. (2007)., 8. Dc, 138–144. 10.1097/01.PCC.0000257039.32593.DC Analysis of the evidence for the lower limit of systolic and mean arterial pressure in children Pediatr. Crit. Care Med. 2
    1. Horikoshi Y., Kuratani N., Tateno K., Hoshijima H., Nakamura T., Mieda T., et al. (2021). Anesthetic management with remimazolam for a pediatric patient with Duchenne muscular dystrophy. Med. Baltim. 100 (49), e28209. 10.1097/md.0000000000028209
    1. Jalota L., Kalira V., George E., Shi Y. Y., Hornuss C., Radke O., et al. (2011). Prevention of pain on injection of propofol: Systematic review and meta-analysis. Bmj 342, d1110. 10.1136/bmj.d1110
    1. Jenkins B. N., Kain Z. N., Kaplan S. H., Stevenson R. S., Mayes L. C., Guadarrama J., et al. (2015). Revisiting a measure of child postoperative recovery: Development of the post hospitalization behavior questionnaire for ambulatory surgery. Paediatr. Anaesth. 25 (7), 738–745. 10.1111/pan.12678
    1. Jung S. M., Lee E., Park S. J. (2019). Validity of bispectral index monitoring during deep sedation in children with spastic cerebral palsy undergoing injection of botulinum toxin. Korean J. Anesthesiol. 72 (6), 592–598. 10.4097/kja.19129
    1. Kamata K., Asagi S., Shimoda Y., Kanamori M., Abe N., Sugino S., et al. (2022). Successful recording of direct cortical motor-evoked potential from a pediatric patient under remimazolam anesthesia: A case report. JA Clin. Rep. 8 (1), 66. 10.1186/s40981-022-00555-y
    1. Keam S. J. (2020). Remimazolam: First approval. Drugs 80 (6), 625–633. 10.1007/s40265-020-01299-8
    1. Kilpatrick G. J., McIntyre M. S., Cox R. F., Stafford J. A., Pacofsky G. J., Lovell G. G., et al. (2007). CNS 7056: A novel ultra-short-acting benzodiazepine. Anesthesiology 107 (1), 60–66. 10.1097/01.anes.0000267503.85085.c0
    1. Klockars J. G., Hiller A., Ranta S., Talja P., van Gils M. J., Taivainen T. (2006). Spectral entropy as a measure of hypnosis in children. Anesthesiology 104 (4), 708–717. 10.1097/00000542-200604000-00015
    1. Lang B., Zhang L., Zhang W., Lin Y., Fu Y., Chen S. (2020). A comparative evaluation of dexmedetomidine and midazolam in pediatric sedation: A meta-analysis of randomized controlled trials with trial sequential analysis. CNS Neurosci. Ther. 26 (8), 862–875. 10.1111/cns.13377
    1. Lauder G. R. (2015). Total intravenous anesthesia will supercede inhalational anesthesia in pediatric anesthetic practice. Paediatr. Anaesth. 25 (1), 52–64. 10.1111/pan.12553
    1. Lee A. C., Redding A. T., Tjia I., Rana M. S., Heitmiller E. (2021). Self-reported awareness during general anesthesia in pediatric patients: A study from wake up safe. Paediatr. Anaesth. 31 (6), 676–685. 10.1111/pan.14176
    1. Lei L., Katznelson R., Fedorko L., Carroll J., Poonawala H., Machina M., et al. (2017). Cerebral oximetry and postoperative delirium after cardiac surgery: A randomised, controlled trial. Anaesthesia 72 (12), 1456–1466. 10.1111/anae.14056
    1. Pastis N. J., Yarmus L. B., Schippers F., Ostroff R., Chen A., Akulian J., et al. (2019). Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy. Chest 155 (1), 137–146. 10.1016/j.chest.2018.09.015
    1. Rex D. K., Bhandari R., Desta T., DeMicco M. P., Schaeffer C., Etzkorn K., et al. (2018). A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest. Endosc. 88 (3), 427–437. 10.1016/j.gie.2018.04.2351
    1. Rex D. K., Bhandari R., Lorch D. G., Meyers M., Schippers F., Bernstein D. (2021). Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial. Dig. Liver Dis. 53 (1), 94–101. 10.1016/j.dld.2020.10.039
    1. Russell I. F. (1993). Midazolam-alfentanil: An anaesthetic? An investigation using the isolated forearm technique. Br. J. Anaesth. 70 (1), 42–46. 10.1093/bja/70.1.42
    1. Schüttler J., Eisenried A., Lerch M., Fechner J., Jeleazcov C., Ihmsen H. (2020). Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: Part I. Pharmacokinetics and clinical pharmacodynamics. Anesthesiology 132 (4), 636–651. 10.1097/aln.0000000000003103
    1. Sheng X. Y., Liang Y., Yang X. Y., Li L. E., Ye X., Zhao X., et al. (2020). Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers. Eur. J. Clin. Pharmacol. 76 (3), 383–391. 10.1007/s00228-019-02800-3
    1. Shioji N., Everett T., Suzuki Y., Aoyama K. (2022). Pediatric sedation using dexmedetomidine and remimazolam for magnetic resonance imaging. J. Anesth. 36 (1), 1–4. 10.1007/s00540-021-02957-1
    1. Shirozu K., Nobukuni K., Tsumura S., Imura K., Nakashima K., Takamori S., et al. (2022). Neurological sedative indicators during general anesthesia with remimazolam. J. Anesth. 36 (2), 194–200. 10.1007/s00540-021-03030-7
    1. Sikich N., Lerman J. (2004). Development and psychometric evaluation of the pediatric anesthesia emergence delirium scale. Anesthesiology 100 (5), 1138–1145. 10.1097/00000542-200405000-00015
    1. Stöhr T., Colin P. J., Ossig J., Pesic M., Borkett K., Winkle P., et al. (2021). Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment. Br. J. Anaesth. 127 (3), 415–423. 10.1016/j.bja.2021.05.027
    1. Urits I., Peck J., Giacomazzi S., Patel R., Wolf J., Mathew D., et al. (2020). Emergence delirium in perioperative pediatric care: A review of current evidence and New directions. Adv. Ther. 37 (5), 1897–1909. 10.1007/s12325-020-01317-x
    1. Varghese E., Krishna H. M., Nittala A. (2010). Does the newer preparation of propofol, an emulsion of medium/long chain triglycerides cause less injection pain in children when premixed with lignocaine? Paediatr. Anaesth. 20 (4), 338–342. 10.1111/j.1460-9592.2010.03272.x
    1. Zhang X., Li S., Liu J. (2021). Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: Single-centre randomized controlled trial. BMC Anesthesiol. 21 (1), 156. 10.1186/s12871-021-01373-y
    1. Zhou J., Leonowens C., Ivaturi V. D., Lohmer L. L., Curd L., Ossig J., et al. (2020). Population pharmacokinetic/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects. J. Clin. Anesth. 66, 109899. 10.1016/j.jclinane.2020.109899

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere